Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
about
Understanding attention-deficit/hyperactivity disorder from childhood to adulthoodTreatment of adults with attention-deficit/hyperactivity disorderTreatment of adults with attention-deficit/hyperactivity disorderImpulsive delayed reward discounting as a genetically-influenced target for drug abuse prevention: a critical evaluationPreclinical evaluation of reconsolidation blockade by clonidine as a potential novel treatment for posttraumatic stress disorderA randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder.Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder.An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics.A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.Changes of Heart Rate Variability during Methylphenidate Treatment in Attention-Deficit Hyperactivity Disorder Children: A 12-Week Prospective StudyAdolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Dispensable, redundant, complementary, and cooperative roles of dopamine, octopamine, and serotonin in Drosophila melanogaster.Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task.Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder.Management of attention-deficit hyperactivity disorder.Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.Do college students improve their grades by using prescription stimulants nonmedically?
P2860
Q22241209-1231C9FE-F4E5-462B-965B-50E9C559CEDBQ24642937-F29F8A63-A5C9-49DD-89F3-49A6A1718E88Q24644586-A31C8051-A4CA-4544-8B10-D952A5B8914BQ26782950-81C2D797-2159-46F2-ADF3-CC8197293ECDQ30446686-A4100983-4045-4350-AAB7-C6FBF7059362Q33632093-38C40B5C-D0F5-44B0-B5F2-0B63B156F563Q33800284-7BF778F6-9588-4770-AC86-01E202524BFCQ33819917-037AB589-DF08-4A30-9690-5A7470660FE3Q33819929-58B0D4E4-986D-430B-B990-DD519C96C472Q34650130-D0D8990B-E2BC-4CEB-BC70-0EF495D0F67BQ35755882-BF19E6AE-B619-4EDF-850B-E469B8B9868BQ35971128-942A93C6-93F6-4B77-8ECB-A3D684EB31A1Q36372705-30F6653F-BE84-45DF-9096-124791A32B9EQ36480380-62AF5096-E355-4237-8367-15165D10AB08Q36666847-4507E27E-71C6-4E88-AB0B-58431BB82C4BQ37336825-E58025BD-F8AC-4DEB-B12A-159DB12F1DD3Q37374833-5153B008-ED1C-417C-B31E-18CD61E77404Q37680047-1CD95452-10C1-4ABE-A4B7-BE1037637F22Q38445841-737FF717-B777-4AC9-950E-B6BA169FE2F7Q39252587-087493BA-2554-44C0-832E-46D3E8A9F294Q49726241-9E0E0731-7473-48D9-B1BE-C7D8C04F17EA
P2860
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@ast
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@en
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@nl
type
label
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@ast
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@en
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@nl
prefLabel
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@ast
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@en
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@nl
P1476
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
@en
P2093
Timothy E Wilens
P478
67 Suppl 8
P577
2006-01-01T00:00:00Z